This study is testing whether an experimental medication called SPG302 can help control symptoms and improve brain function in adults with schizophrenia. Thirty-two participants will take either SPG302 or a placebo pill daily for six weeks while researchers measure changes in sym…
Phase: PHASE2 • Sponsor: Spinogenix • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC